{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_5", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "rom human and animal data. These letter categories were overly simplistic, and \ndid not effe ctively communicate the risk a drug may have during pregnancy and lactation. \nHeavy reliance upon pregnancy categories often led to misinterpretation of the information, \nmaking prescribing decisions based on the pregnancy category rather than an understandi ng of \nthe underlying information that informed the assignment of the pregnancy category. FDA believes \nthat a narrative structure for pregnancy lab"}